SlipstreamJobs tracks this role from the company's public career site. Apply directly on the employer's site.
Salary: USD 170,871 - 314,449 / annual
BillionToOne is a publicly traded genomics company transforming healthcare through precision diagnostics in prenatal and cancer care. We are seeking a field-based Oncology Account Executive based in Roanoke, VA to drive sales of our Northstar liquid biopsy products to oncologists and cancer care providers in your territory.
You will own revenue growth and market development in your geography through direct sales to individual oncologists and cancer care centers. Your responsibilities include creating and executing a strategic business plan to grow revenue, prospecting and cultivating new business relationships, and maintaining key accounts. You'll work independently with strong internal drive while reporting to a Regional Manager - Oncology.
Required qualifications include a Bachelor's degree (or equivalent), a demonstrated track record of sales success (Presidents Club, Chairman's Club, Rookie of the Year, or consistent quota attainment), and experience selling to medical providers in medical diagnostics, devices, or related fields. You must live within your defined territory and be willing to travel extensively. The ideal candidate is exceptionally bright, self-motivated, results-oriented, and thrives in a startup environment with a sense of urgency around closing business.
Alternatively, we welcome applications from Physician Assistants (PA), Nurse Practitioners (NP), or Registered Nurses (RN) with experience ordering late-stage cancer liquid biopsy tests.
BillionToOne offers competitive total compensation including base salary, uncapped commission potential, and generous equity. Additional benefits include 100% employer-paid medical premiums for select plans, 16 weeks paid family bonding leave, fertility benefits, 4% 401(k) match, and increasing PTO with tenure. You'll work alongside passionate innovators in a transparent, collaborative culture with weekly town halls, contributing directly to improving outcomes for hundreds of thousands of patients.
